Bioxcel Therapeutics(DE:BX20)
€0.070.00 (0.00%)
DE:BX20
Bioxcel Therapeutics earnings date
€0.07
At close:0.00 (0.00%)
Bioxcel Therapeutics (BX20) Q2 2021 Earnings Report
10 Followers
DE:BX20 Q2 2021 EPS Results
- Actual EPS
- -EUR 16.19
- Consensus EPS
- -EUR 15.63
- Beat/Miss
- Missed by -EUR 0.56
- One Year Ago EPS
- -EUR 15.46
DE:BX20 Q2 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/10/2021
- Time
- Before Open
- Conference Call
- Tuesday, August 10, 2021
DE:BX20 Upcoming Earnings
Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BX20 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | ―- | -0.53 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | -0.92- | -1.99 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.40-0.44 | -2.23 | 80.16% (+1.79) | |
| May 15, 2026 | 2026 (Q1) | -0.48-0.49 | -1.37 | 64.00% (+0.88) | |
| Mar 27, 2026 | 2025 (Q4) | -0.58-0.53 | -3.25 | 83.75% (+2.73) | |
| Nov 12, 2025 | 2025 (Q3) | -1.22-1.99 | -4.67 | 57.42% (+2.68) | |
| Aug 12, 2025 | 2025 (Q2) | -1.69-2.23 | -3.06 | 27.08% (+0.83) | |
| May 12, 2025 | 2025 (Q1) | -2.48-1.37 | -12.69 | 89.22% (+11.32) | |
| Mar 27, 2025 | 2024 (Q4) | -5.51-3.25 | -11.08 | 70.64% (+7.83) | |
| Nov 14, 2024 | 2024 (Q3) | -7.37-4.67 | -25.09 | 81.40% (+20.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

